New Key Statistics Module, Z-Score and F-Score
OTCPK:IMMVF Key Ratios
| Market Cap $ M | 8.40 |
| Enterprise Value $ M | 3.62 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 0.10 |
| Price/Book | 2.76 |
| Price/Sales | 78.38 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.15 |
| Beneish M-Score | -6.24 |
| 10-y EBITDA Growth Rate % | -42.50 |
| 5-y EBITDA Growth Rate % | -0.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.49 |
| EV-to-EBITDA | -0.56 |
| PEG | -- |
| Shares Outstanding M | 169.71 |
| Net Margin (%) | -20,353.01 |
| Operating Margin % | -16,274.21 |
| Pre-tax Margin (%) | -20,353.01 |
| Quick Ratio | 2.36 |
| Current Ratio | 2.36 |
| ROA % (ttm) | -145.95 |
| ROE % (ttm) | -245.28 |
| ROIC % (ttm) | -215.37 |
| Dividend Yield % | -- |
| Altman Z-Score | -27.77 |
IMMVF Number of Guru Trades
IMMVF Volume of Guru Trades
Gurus Latest Trades with OTCPK:IMMVF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:IMMVF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Immunovia AB Insider Transactions
No Available Data
News about OTCPK:IMMVF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers